Aer Therapeutics

Durham, United Kingdom · Founded 2014 · Privately Held (backing)

Operator of a biopharmaceutical company intended to treat lung disease with excess mucus and mucus plugs. Aer Therapeutics is based in Durham, United Kingdom and was founded in 2014. It was valued at $58 million at a debt round in Mar 2025, the last priced event on record. It has raised $48 million across 2 recorded rounds; the latest was a $5 million early-stage round in Jan 2025.

PMV mark · valuation
$58.0M
Oct 2026
Priced at
a debt round
Mar 2025
Total raised
$48.0M
Last round
Early Stage VC
Jan 2025

Who backs Aer Therapeutics?

6 investors
InvestorType
National Institutes of HealthOther
OrbiMedGrowth equity
Canaan PartnersVenture capital
Hatteras Venture PartnersVenture capital
NovaUCD—
Pappas Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Aer Therapeutics investors

6 investors are on record for Aer Therapeutics, including National Institutes of Health, OrbiMed, Canaan Partners and Hatteras Venture Partners. The early-stage round in Jan 2025 drew 15 investors.

Free account
More of Aer Therapeutics with a free account
  • ·Watch Aer Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Aer Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View